CARDIOGEN 20 MG
$125.00
Khavinson cardiac-targeted tetrapeptide bioregulator for cardiomyocyte research. ≥98% purity, 20 mg lyophilized. For laboratory research only.
- 🔒 Secure Checkout
- ↩️ 30-Day Easy Returns
- ⭐ Premium Quality Guaranteed
🛍️ Frequently Bought Together
Description
Research Profile
Developed through the St. Petersburg Institute of Bioregulation and Gerontology, Cardiogen demonstrates selective tissue tropism for cardiomyocytes. Published research has investigated its effects on cardiac-specific gene expression, cardiomyocyte proliferation markers, extracellular matrix organization in cardiac tissue, and cardioprotective mechanisms under ischemia-reperfusion stress conditions. It represents a targeted approach to cardiovascular peptide bioregulation.





Reviews
There are no reviews yet.